Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction

ArticleAçık Erişim

Özet

The aim of study was to determine the effects of ozone therapy on the oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction (HFrEF). A total of 40 patients with New York Heart Association 2 and 3 HF with left ventricular ejection fraction (LVEF) <35%, and 40 subjects without HF as control group were included in the study. Patients with HFrEF were given additional ozone therapy of major and minor administrations along with conventional HF treatment for 5 weeks. Before and after ozone therapy, left ventricular end-systolic and end-diastolic volumes (LVESV, LVEDV) and the 6 minute walk distance (6MWD) and blood levels of the superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione peroxidase (GSHPx), malondialdehyde (MDA), nitric oxide (NO) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were measured. Ozone therapy significantly reduced the serum levels of NO and MDA (p < 0.001, respectively) and significantly increased the levels of SOD, CAT, GSH and GSHPx (p < 0.001, respectively). LVEDV and LVESV were found to be significantly reduced; however, LVEF was not found to be significantly increased (p = 0.567). As the biochemical improvement marker of HF, NT-proBNP was significantly reduced (p < 0.001). The clinical HF improvement marker of 6 minute walk distance was also modestly increased (p < 0.001). Ozone therapy might be beneficial in terms of activating antioxidant system and merit further therapeutic potential to conventional HF treatment in patients with HFrEF. © 2017, Springer Science+Business Media New York.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14540Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s12012-017-9400-8Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBuyuklu, Mutlu
dc.contributor.authorKandemir, Fatih Mehmet
dc.contributor.authorSet, Turan
dc.contributor.authorBakırcı, Eftal Murat
dc.contributor.authorDegirmenci, Husnu
dc.contributor.authorHamur, Hikmet
dc.contributor.authorTopal, Ergun
dc.contributor.authorKucukler, Sefa
dc.contributor.authorTurkmen, Kultigin
dc.date.accessioned2026-10-18T20:29:21.088120184Z
dc.date.available2026-10-18T20:29:21.088120184Z
dc.date.issued2017
dc.description.abstractThe aim of study was to determine the effects of ozone therapy on the oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction (HFrEF). A total of 40 patients with New York Heart Association 2 and 3 HF with left ventricular ejection fraction (LVEF) <35%, and 40 subjects without HF as control group were included in the study. Patients with HFrEF were given additional ozone therapy of major and minor administrations along with conventional HF treatment for 5 weeks. Before and after ozone therapy, left ventricular end-systolic and end-diastolic volumes (LVESV, LVEDV) and the 6 minute walk distance (6MWD) and blood levels of the superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione peroxidase (GSHPx), malondialdehyde (MDA), nitric oxide (NO) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were measured. Ozone therapy significantly reduced the serum levels of NO and MDA (p < 0.001, respectively) and significantly increased the levels of SOD, CAT, GSH and GSHPx (p < 0.001, respectively). LVEDV and LVESV were found to be significantly reduced; however, LVEF was not found to be significantly increased (p = 0.567). As the biochemical improvement marker of HF, NT-proBNP was significantly reduced (p < 0.001). The clinical HF improvement marker of 6 minute walk distance was also modestly increased (p < 0.001). Ozone therapy might be beneficial in terms of activating antioxidant system and merit further therapeutic potential to conventional HF treatment in patients with HFrEF. © 2017, Springer Science+Business Media New York.
dc.description.sponsorshipFunding This study was supported by the Scientific Research Fund of Erzincan University.
dc.identifier.doi10.1007/s12012-017-9400-8
dc.identifier.eissn1559-0259
dc.identifier.endpage433
dc.identifier.issn1530-7905
dc.identifier.issue4
dc.identifier.pmid28097518
dc.identifier.scopus2-s2.0-85009822924
dc.identifier.startpage426
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14540
dc.identifier.volume17
dc.identifier.wosWOS:000411104600006
dc.language.isoen
dc.publisherHumana Press Inc.
dc.relation.ispartofCardiovascular Toxicology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntioxidant system
dc.subjectHeart failure
dc.subjectOxidative stress
dc.subjectOzone therapy
dc.subjectAged
dc.subjectCohort Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectInfusions, Intravenous
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectOzone
dc.subjectStroke Volume
dc.subjectTreatment Outcome
dc.subjectVentricular Dysfunction, Left
dc.subjectamino terminal pro brain natriuretic peptide
dc.subjectcatalase
dc.subjectglutathione
dc.subjectglutathione peroxidase
dc.subjectmalonaldehyde
dc.subjectnitric oxide
dc.subjectsuperoxide dismutase
dc.subjectadult
dc.subjectArticle
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectheart failure with reduced ejection fraction
dc.subjectheart left ventricle ejection fraction
dc.subjectheart left ventricle enddiastolic volume
dc.subjectheart left ventricle endsystolic volume
dc.titleBeneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus24
rdl.citation.wos22
rdl.departmentDepartment of Cardiology, Faculty of Medicine, Erzincan University, 24500, Erzincan, Turkey. mutlubuyuklu@gmail.com. | Department of Cardiology, Faculty of Medicine, Erzincan University, 24500, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)